Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Arno Therapeutics, Inc | Financial_Report.xls |
| 10-Q - 10-Q - Arno Therapeutics, Inc | v385436_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - Arno Therapeutics, Inc | v385436_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Arno Therapeutics, Inc | v385436_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Arno Therapeutics, Inc | v385436_ex32-1.htm |
EXHIBIT 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Arno Therapeutics, Inc. (the “ Company ”) hereby certifies, to such officer’s knowledge, that:
(1) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2014 (the “ Report ”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 14, 2014
| /s/ Lawrence A. Kenyon | |
| Name: Lawrence A. Kenyon | |
| Title: Chief Operating Officer and Chief Financial Officer |